This Week’s Big ETF Stories

ETF Trends

It was a holiday-shortened week on Wall Street, but the there and a half trading days that comprised the week were enough time for U.S. stocks to to establish another set of all-time highs.

During Thursday’s half session, the S&P 500 gained 0.55% while the Dow Jones Industrial mustered its first close above the lofty 17,000 level. Adding fuel to the bulls’ fire is the potential for significant upside surprises as second-quarter earnings season starts in the coming days.

“Analysts polled by Reuters are calling for earnings growth for the second quarter of 6.2 percent, and a return to double digits in the third and fourth quarters: 10.9 percent and 11.9 percent, respectively. The last time that S&P 500 earnings achieved double-digit percentage growth was the third quarter of 2011, when the growth rate was 18 percent,” reports Angela Moon for Reuters.

Before looking to the future, let’s have a look at some of this week’s big ETF stories.

ETF Industry News

The real skinny on ETF asset flows. Hint: It’s not just one issuer bringing in the dough. [Plenty of Competitors Gain ETF Assets]

ETFs are gaining traction in retirement accounts, according to a Schwab study.

iShares was the second-quarter inflows leader. [iShares Leads Second-Quarter ETF Flows]

Broad Market Sector ETFs

Health care ETFs keep on soaring, but that pesky valuation talk also remains loud. [Health Care ETFs Rise and Look Pricey]

This momentum ETF is rebounding and growing in a big way.

What some regional bank ETFs have to say about interest rates.

Commodity ETFs

Gold ETFs are on the mend as assets rise. [Gold ETFs Back to Gaining Assets]

Dr. Copper writes a prescription for a healthy global economy.


ETF Trends editorial team contributed to this post.

The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.


View Comments (0)